• Nightingale Health entered an agreement with S-Thetics to offer its blood-based disease risk test in the United Kingdom.
• The test will underpin the clinic's longevity membership, launching in Beaconsfield in November 2026.
• Testing estimates 10-year risk for five chronic diseases from one blood sample, with repeat assessments tracking changes over time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nightingale Health Oyj published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.